AstraZeneca
4 stories
-
healthPharma Giants Invest £450M in UK, Boosting Innovation
AstraZeneca and Boehringer Ingelheim commit significant funds to UK expansion, focusing on research, AI, and new medicines.
-
healthAstraZeneca VP: Redefining Respiratory Care with Early Diagnosis and Targeted Treatments
Andrew Menzies-Gow of AstraZeneca discusses a new era in respiratory medicine, emphasizing early diagnosis, advanced therapies, and patient-centric approaches to improve outcomes.
-
healthHRD Testing in Ovarian Cancer: Expert Guidance for Clinical Practice
Experts discuss homologous recombination deficiency (HRD) testing for ovarian cancer, covering test selection, output interpretation, and integration into patient care pathways.
-
healthCapivasertib Safety Management: Key Steps for US Oncology Teams
AstraZeneca’s TRUQAP®-used with fulvestrant for PIK3CA/AKT1/PTEN-altered HR+/HER2− metastatic breast cancer-requires proactive monitoring for diarrhea, rash, and hyperglycemia.